Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.97%
#3 BankrCoin BankrCoin +19.53%
#4 Ankr Network Ankr Network +17.24%
#5 Hive Hive +16.87%
#6 StonkBroker StonkBroker +16.12%
#7 ICON ICON +13.08%
#8 Status Status +12.07%
#9 Prom Prom +9.87%
#10 Provenance Blockchain Provenance Blockchain +9.17%
Coin of the day
Palladium Network Palladium Network
설정
언어
한국어
통화
USD
테마
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
주식 순위 #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
주가
$5.59
마지막 동기화: 2026-09-02
시가총액
$205.21M
변동 (1일)
6.27%
변동 (1년)
86.33%
국가
US
거래 Armata Pharmaceuticals, Inc. (ARMP)

카테고리

Healthcare
Armata Pharmaceuticals, Inc. (ARMP)의 매출
Sep 2026 기준 매출 TTM: 0
Armata Pharmaceuticals, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Armata Pharmaceuticals, Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH